Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Iodobenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 known ✓ | Q9BY41 | 4/20 | 0.39 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.38 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.35 |
| ▸ | GLA known ✓ | P06280 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TPMT | P51580 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodobenzene SCHEMBL2250668 | 1.00 | — | — | |
| Iodobenzene SCHEMBL205035 | 1.00 | — | — | |
| Iodobenzene SCHEMBL28210359 | 0.96 | — | — | |
| Iodobenzene SCHEMBL10538620 | 0.96 | ALDH1A1 (0.43) | ALDH1A1APPHDAC8TPMTTSHR | |
| Iodobenzene SCHEMBL3628957 | 0.96 | — | — | |
| Iodobenzene SCHEMBL1587 | 0.96 | — | — | |
| Iodobenzene SCHEMBL10481785 | 0.96 | ALDH1A1 (0.43) | ALDH1A1APPHDAC8TPMTTSHR | |
| Iodobenzene SCHEMBL1331855 | 0.96 | — | — | |
| Iodobenzene SCHEMBL28043342 | 0.93 | TSHR (0.39) | ALDH1A1APPHDAC8TPMTTSHR | |
| Iodobenzene SCHEMBL10616506 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118994170-A | Process for preparing 1' -cyanonucleosides | 吉利德科学公司 | 2024-11-22 | — | — | CN | claimed |
| US-12110271-B2 | Manufacturing method for 4-methoxypyrrole derivatives | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2024-10-08 | — | — | US | claimed |
| US-12012431-B2 | Methods of preparing 1′-cyano nucleosides | GILEAD SCIENCES, INC. (US) | 2024-06-18 | — | — | US | claimed |
| CN-117603275-A | Preparation method of polyketone catalyst and application of polyketone catalyst in catalyzing polyketone synthesis | 万华化学集团股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| US-20230295214-A1 | METHODS OF PREPARING 1`-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. | 2023-09-21 | — | — | US | claimed |
| WO-2023007426-A1 | NOVEL STYRENE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF | PI INDUSTRIES LTD. (IN) | 2023-02-02 | — | — | WO | claimed |
| WO-2023007429-A1 | PREPARATION OF PHENYL SULFILIMINES OR SULFOXIMINES CONTAINING THIAZOLYL-PIPERIDINYL COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2023-02-02 | — | — | WO | claimed |
| CN-115298181-A | Process for preparing 1' -cyanonucleosides | 吉利德科学公司 | 2022-11-04 | — | — | CN | claimed |
| US-20210309689-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. | 2021-10-07 | — | — | US | claimed |
| EP-3854784-A1 | METHOD FOR PRODUCING 4-METHOXY PYRROLE DERIVATIVE | Daewoong Pharmaceutical Co., Ltd. (KR) | 2021-07-28 | — | — | EP | claimed |
| EP-0124278-A2 | Improved process for the manufacture of halogenated polymers | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-11-07 | — | — | EP | claimed |
| EP-0002564-B1 | DERIVATIVES OF 7-OXO-1-AZABICYCLO(3.2.0)-HEPT-2-ENE-2-CARBOXYLIC ACID, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES | BEECHAM GROUP PLC (GB) | 1984-06-20 | — | — | EP | claimed |
| US-4358607-A | CHLORINATION, DEHYDROCHLORINATION, HYDROLYSIS | AMERICAN CYANAMID CO. (US) | 1982-11-09 | — | — | US | claimed |
| EP-0005523-B1 | D-HOMOSTEROIDS, PROCESS FOR THEIR PREPARATION | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-08-26 | — | — | EP | claimed |
| EP-0003863-B1 | NOVEL ANDROSTADIENES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Technobiotic Ltd. (CH) | 1981-07-22 | — | — | EP | claimed |
| EP-0003863-A1 | Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them | Technobiotic Ltd. (CH) | 1979-09-05 | — | — | EP | claimed |
| EP-0002564-A1 | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates | BEECHAM GROUP PLC (GB) | 1979-06-27 | — | — | EP | claimed |
| US-4100201-A | Process for the preparation of halogenoacetals from esters | RHONE-POULENC INDUSTRIES (FR) | 1978-07-11 | — | — | US | claimed |
| US-4087465-A | Process for the preparation of halogeno-acetals from enoxysilanes | RHONE-POULENC INDUSTRIES (FR) | 1978-05-02 | — | — | US | claimed |
| US-4061661-A | Δ9(11) -5α-20-KETO STEROIDS AND PROCESS FOR THEIR PRODUCTION | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012431-B2 | Methods of preparing 1′-cyano nucleosides | PNP, TYMP, RNGTT | HDAC8 3619/4885ACHE 1718/4885CA2 3026/4885 |
| US-20230295214-A1 | METHODS OF PREPARING 1`-CYANO NUCLEOSIDES | PNP, TYMP, DUT | HDAC8 3671/4885ACHE 1406/4885CA2 3089/4885 |
| US-12110271-B2 | Manufacturing method for 4-methoxypyrrole derivatives | COMT, TH, HPD | HDAC8 4872/4885ACHE 1320/4885CA2 4359/4885 |
| US-20210309689-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | PNP, TYMP, DUT | HDAC8 3667/4885ACHE 1631/4885CA2 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.